NCT06537323 Femoral Nerve Block, Periarticular Nerve Group (PENG) Block, and Preoperative IV Fentanyl
| NCT ID | NCT06537323 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Aswan University Hospital |
| Condition | Postoperative Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 210 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2024-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 210 participants in total. It began in 2024-06-01 with a primary completion date of 2024-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The pericapsular nerve group block is a regional anesthetic technique described in 2018, developed primarily in total hip arthroplasties for postoperative analgesia with motor sparing benefits. The block is thought to provide more complete analgesia to the hip by depositing local anesthetic within the myofascial plane of the psoas muscle and superior pubic ramus. The indications for total hip arthroplasties often include degenerative hip disease and traumatic hip fractures. These indications for surgery are relatively common in the elderly population and are associated with significant morbidity and mortality.
Eligibility Criteria
Inclusion Criteria: * The included patient should be between 55 to 69 years Exclusion Criteria: * known allergies to local anesthetics
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06537323 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, up to 69 Years, studying Postoperative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06537323 currently recruiting?
Yes, NCT06537323 is actively recruiting participants. Contact the research team at tarek.said@aswu.edu.eg for enrollment information.
Where is the NCT06537323 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06537323 clinical trial?
NCT06537323 is sponsored by Aswan University Hospital. The trial plans to enroll 210 participants.